1.Epithelioid trophoblastic tumor of the ovary: report of a case.
Chinese Journal of Pathology 2023;52(11):1174-1176
4.Epithelioid trophoblastic tumor of the uterus: a report of.
Qi LIU ; Qun-Li SHI ; Jian-Min ZHANG ; Yan LI ; Yi-Ming DU ; Shi-Ming SHEN ; Heng-Hui MA ; Kui MENG
Chinese Medical Journal 2007;120(8):729-730
Adult
;
Epithelioid Cells
;
pathology
;
Fatal Outcome
;
Female
;
Humans
;
Hysterectomy
;
Middle Aged
;
Trophoblastic Neoplasms
;
pathology
;
surgery
;
Uterine Neoplasms
;
pathology
;
surgery
5.Intermediate trophoblastic tumor in omentum.
Hai-tao YANG ; Shao-min YANG ; Song-lin LIAO ; Wen WANG ; Ling-li MENG
Chinese Journal of Pathology 2007;36(4):277-278
Adult
;
Diagnosis, Differential
;
Female
;
Humans
;
Keratin-18
;
metabolism
;
Mucin-1
;
metabolism
;
Omentum
;
metabolism
;
pathology
;
Peritoneal Neoplasms
;
metabolism
;
pathology
;
ultrastructure
;
Pregnancy
;
Trophoblastic Neoplasms
;
metabolism
;
pathology
;
ultrastructure
;
Trophoblastic Tumor, Placental Site
;
pathology
;
Vimentin
;
metabolism
6.Expression of R2 protein in gestational trophoblastic diseases.
Jin-quan CUI ; Yi-fu SHI ; Huai-jun ZHOU
Journal of Zhejiang University. Medical sciences 2004;33(5):433-436
OBJECTIVETo study the expression of the small subunit ribonucleotide reductase (R2) in gestational trophoblastic diseases (GTD) and to assess its prognostic value.
METHODSThe expression of R2 was detected with immunohistochemical method in 15 cases of normal villi, 38 cases of hydatidiform mole (HM), 42 cases of invasive moles (IM) and 18 cases of choriocarcinoma (CC).
RESULTSR2 expression in HM, IM and CC was significantly increased compared with that of normal villi (P=0.000). There were no significant differences in R2 protein expression among HM, IM and CC. Among 38 cases of HM, R2 expression in 8 cases with malignant transformation was significantly higher than in 30 cases of non-malignant transformation mole (P=0.02). Preoperative chemotherapy of gestational trophoblastic tumor including IM and CC did not influence the R2 expression. Compared with patients of stage I (WHO), the R2 protein in gestational trophoblastic tumor (GTT) patients of stage III or stage II was significantly increased (P=0.023 and P=0.038, respectively). The value of R2 in GTT patients with middle or high risk in WHO prognostic scoring system was higher than in the patients with low risk (P=0.018 and P=0.006, respectively).
CONCLUSIONR2 expression in GTD is increased, which may be associated with the hyperplasia of trophoblasts, malignant transformation of hydatidiform mole and drug resistance of trophoblastic tumor.
Adult ; Female ; Gestational Trophoblastic Disease ; enzymology ; pathology ; Humans ; Pregnancy ; Ribonucleotide Reductases ; biosynthesis ; genetics ; Uterine Neoplasms ; enzymology ; pathology
7.Clinicopathological study of intermediate trophoblastic non-tumor lesions: exaggerated placental site and placental site nodule.
Dan-hua SHEN ; Xiao-yun LIAO ; Yan-li LIU ; Hua WANG ; You-zhi YU
Chinese Journal of Pathology 2004;33(5):441-444
OBJECTIVETo investigate the clinicopathological features of intermediate trophoblastic non-tumor lesions, and to evaluate the position of immunohistochemistry in differential diagnoses.
METHODSClinical presentation and morphological study of 15 cases of exaggerated placental site (EPS) and 4 cases of placental site nodule or plaque (PSNP) were reviewed. Immunohistochemical stains for hCG, hPL, inhibin-alpha, PLAP, CK18 and Ki-67 were performed.
RESULTSThe age of patients ranged from 25 to 40 years with an average of 31.5 years for EPS and 26 to 39 years with an average of 34.3 years for PSNP. Microscopically, EPS was characterized by cords and small sheets of implantation site intermediate trophoblasts infiltrating the endometrium, myometrium and arterial walls. The general histological structures of the endometrium and myometrium were preserved. PSNP was characterized by multiple circumscribed nodular lesions consisting of so-called chorionic-type intermediate trophoblasts and hyaline-like matrix present in the endometrium. Immunohistochemical stainings for hPL and CK18 were positive in the 15 EPS cases. Immunoreactivity for CK18, Inhibin-alpha and PLAP was detected in 4 PSNP cases. The Ki-67 labeling index in 15 EPS cases was low (< or = 5%), while Ki-67 index in 4 PSNP cases was close to 0.
CONCLUSIONSThe clinical presentation and pathological features of EPS and PSNP differ from those of trophoblastic tumors (placental site trophoblastic tumor, epithelioid trophoblastic tumor and choriocarcinoma). Immunochemical staining is of great value in their differential diagnoses.
Adult ; Diagnosis, Differential ; Endometrium ; pathology ; Female ; Follow-Up Studies ; Humans ; Hysterectomy ; methods ; Inhibins ; metabolism ; Keratins ; metabolism ; Myometrium ; pathology ; Placenta ; metabolism ; pathology ; Placenta Diseases ; metabolism ; pathology ; surgery ; Placental Lactogen ; metabolism ; Pregnancy ; Trophoblastic Neoplasms ; pathology ; Trophoblastic Tumor, Placental Site ; pathology ; Trophoblasts ; pathology ; Uterine Neoplasms ; pathology
8.Low-dose spiral CT versus standard dose CT in detection of pulmonary metastasis from gestational trophoblastic tumor.
Xiao-jun XU ; Fen-lan LOU ; Min-ming ZHANG ; Zhi-mei PAN
Chinese Journal of Oncology 2006;28(5):377-380
OBJECTIVEThe purpose of this study is to investigate whether low-dose spiral chest CT scan can replace standard-dose CT scan in detecting pulmonary metastases for patients with gestational trophoblastic tumor (GTT).
METHODSTotally, 34 GTT patients underwent 56 chest CT scans for the assessment of pulmonary metastasis. All patients received CT examination both at standard-dose (120 KV, 150 mAs, pitch 1, and a standard reconstruction algorithm) and low-dose CT (120 KV, 40 mAs, pitch 2, and a bone reconstruction algorithm) simultaneously each time. The images were interpreted by two radiologists independently. A metastasis by CT image was defined as a nodule within lung parenchyma that could not be attributed to a pulmonary vessel. The number of lesions detected at each dose protocol was recorded. The size of each lesion was measured and categorized as < 5 mm, 5 - 10 mm or > or = 10 mm. The differences in detection of the lesions between the standard- and low-dose CT protocols were compared using Wilconxon signed rank test.
RESULTS1417 lesions were detected at the standard-dose, whereas 1214 lesions were found by low-dose CT. Lesions < 5 mm detected by low-dose CT were fewer than that detected by standard-dose CT (Z = -3.368, P = 0.000), though there was no statistically significant difference between the standard- and low-dose CT in detecting lesion > or = 5 mm (Z = -0.055, P = 0.957). Moreover, the risk score of the patients was not affected either. The sensitivity of low-dose CT was 69.16% for all size of lesions, 58.50% for < 5 mm, 87.07% for 5 - 10 mm, and 97.01% for > or = 10 mm. The positive predictive value for different sizes of lesion was 80.71% (all sizes), 73.82% (5 mm), 88.86% (5 - 10 mm), and 98.48% (> or = 10 mm), respectively.
CONCLUSIONLow-dose chest CT can replace the standard-dose chest CT as a screening and follow-up examination to assess the change in pulmonary metastasis for patients with gestational trophoblastic tumor.
Adult ; Female ; Gestational Trophoblastic Disease ; diagnostic imaging ; secondary ; Humans ; Lung Neoplasms ; diagnostic imaging ; secondary ; Middle Aged ; Pregnancy ; Radiation Dosage ; Tomography, Spiral Computed ; methods ; Uterine Neoplasms ; pathology
9.Uterine epithelioid trophoblast tumor: report of a case.
Mei-fu GAN ; Chun-kai YU ; Hong-sheng LU ; Pei-nong YANG
Chinese Journal of Pathology 2007;36(8):570-571
Abdominal Neoplasms
;
secondary
;
surgery
;
Abdominal Wall
;
Antiporters
;
metabolism
;
Choriocarcinoma
;
pathology
;
Diagnosis, Differential
;
Epithelioid Cells
;
pathology
;
Female
;
Gestational Trophoblastic Disease
;
metabolism
;
pathology
;
secondary
;
surgery
;
Humans
;
Pregnancy
;
Uterine Neoplasms
;
metabolism
;
pathology
;
surgery
;
Young Adult
10.The influence of lung metastasis on prognosis of previously untreated gestational trophoblastic neoplasia patients.
Jin Jie LIN ; Fang JIANG ; Yang XIANG ; Xi Rui WAN ; Feng Zhi FENG ; Tong REN ; Jun Juan YANG ; Jun ZHAO
Chinese Journal of Oncology 2022;44(10):1139-1145
Objective: To investigate the impact of lung metastases on the prognosis of patients with gestational trophoblastic neoplasia (GTN). Methods: Patients with International Federation of Gynaecology and Obstetrics (FIGO) stage Ⅰ-Ⅲ GTN receiving primary chemotherapy in Peking Union Medical College Hospital between July 2014 and December 2018 were retrospectively analyzed and divided into group 1 with lung metastasis and group 2 without lung metastasis. The baseline characteristics and treatment outcomes of the two groups were compared. The optimal cut-off values of the diameter of largest lung nodule associated with recurrence were identified by receiver operating characteristic (ROC) curves. Logistic regression analyses were performed to identify risk factors for prognosis. Survival analysis was performed by Kaplan-Meier method and Log rank test. Results: Of the 381 GTN patients enrolled (216 with lung metastases and 165 without lung metastases), the pretreatment β human chorionic gonadotrophin [median: 12 572 IU/L (1 832-51 594 IU/L) vs. 5 614 IU/L (559-26 140 IU/L), P=0.001] and FIGO score [median: 3 (1-6) vs. 2 (1-4), P=0.038] were significantly higher in patients with lung metastases than those without lung metastases. In patients with FIGO score≥5, the emergence of resistance (26.76% vs. 10.26%, P=0.036) and median number of chemotherapy courses to achieve complete remission [6 (6-8) vs. 5 (4-6), P<0.001] were significantly higher than patients with lung metastases. In patients with FIGO score 0-4, no significant difference was found in the treatment outcomes between the two groups(P=0.833). Among all patients with lung metastases, the ROC curve showed a sensitivity and specificity of 62.5% and 78.8%, respectively, for predicting recurrence when the length of the largest lung nodule was 1.6 cm, with an area under the curve (AUC) of 0.711 (95% CI: 0.550, 0.871, P=0.044). Multivariate logistic regression analysis suggested a significantly higher recurrence rate when the largest lung nodule was ≥1.6 cm (OR=7.394, 95% CI: 1.003, 54.520, P=0.049). The 1-year disease-free survival rate was significantly lower in patients with the largest lung nodule ≥1.6 cm than in patients with the nodule <1.6 cm (98.2% vs. 82.4%, P=0.001). Conclusions: Lung metastasis is associated with increased first-line chemotherapy resistance in patients with FIGO scores≥5. The diameter of the largest lung metastatic nodule ≥1.6 cm is an effective factor for predicting recurrence.
Pregnancy
;
Female
;
Humans
;
Retrospective Studies
;
Gestational Trophoblastic Disease/pathology*
;
Prognosis
;
Lung Neoplasms/drug therapy*
;
Disease-Free Survival
;
Antineoplastic Combined Chemotherapy Protocols/therapeutic use*